[go: up one dir, main page]

NL301097I1 - - Google Patents

Info

Publication number
NL301097I1
NL301097I1 NL301097C NL301097C NL301097I1 NL 301097 I1 NL301097 I1 NL 301097I1 NL 301097 C NL301097 C NL 301097C NL 301097 C NL301097 C NL 301097C NL 301097 I1 NL301097 I1 NL 301097I1
Authority
NL
Netherlands
Application number
NL301097C
Other languages
Dutch (nl)
Other versions
NL301097I2 (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP12733505.7A external-priority patent/EP2734522B1/en
Application filed filed Critical
Publication of NL301097I1 publication Critical patent/NL301097I1/nl
Publication of NL301097I2 publication Critical patent/NL301097I2/en

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
NL301097C 2011-07-19 2021-03-22 acalabrutinib or a pharmaceutically acceptable salt thereof NL301097I2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201161509397P 2011-07-19 2011-07-19
EP11174578 2011-07-19
EP12733505.7A EP2734522B1 (en) 2011-07-19 2012-07-11 4-imidazopyridazin-1-yl-benzamides and 4-imidazotriazin-1-yl-benzamides as btk-inhibitors
PCT/EP2012/063552 WO2013010868A1 (en) 2011-07-19 2012-07-11 4 - imidazopyridazin- 1 -yl-benzamides and 4 - imidazotriazin- 1 - yl - benzamides as btk- inhibitors

Publications (2)

Publication Number Publication Date
NL301097I1 true NL301097I1 (en) 2021-03-24
NL301097I2 NL301097I2 (en) 2021-04-12

Family

ID=67956153

Family Applications (1)

Application Number Title Priority Date Filing Date
NL301097C NL301097I2 (en) 2011-07-19 2021-03-22 acalabrutinib or a pharmaceutically acceptable salt thereof

Country Status (8)

Country Link
CY (1) CY1121174T1 (en)
LT (2) LT3689878T (en)
ME (1) ME03310B (en)
NI (1) NI201400004A (en)
NL (1) NL301097I2 (en)
NO (1) NO2021016I1 (en)
PT (1) PT2734522T (en)
TR (1) TR201901013T4 (en)

Also Published As

Publication number Publication date
LTPA2021004I1 (en) 2021-04-12
NI201400004A (en) 2014-10-10
LT3689878T (en) 2021-11-25
LTC2734522I2 (en) 2022-09-26
TR201901013T4 (en) 2019-02-21
NO2021016I1 (en) 2021-04-09
ME03310B (en) 2019-10-20
NL301097I2 (en) 2021-04-12
CY1121174T1 (en) 2020-05-29
PT2734522T (en) 2019-02-04

Similar Documents

Publication Publication Date Title
BR112013022641A2 (en)
BR112013027245A2 (en)
BR112013024383A2 (en)
BR112013023185A2 (en)
BR112013022995A2 (en)
BR112013026905A2 (en)
BR112013017670A2 (en)
BR112013027830A2 (en)
AP3853A (en)
BR112013026744A2 (en)
BR112013023927A2 (en)
BR112013027452A2 (en)
BR112013024365A2 (en)
BR112013027121A2 (en)
AP2016009466A0 (en)
BR112013024588A2 (en)
BR112013026790A2 (en)
BR112013027836A2 (en)
BR112013018949A2 (en)
BR112013026895A2 (en)
BR112013027761A2 (en)
BR112013021637A2 (en)
BR112013023266A2 (en)
BR112013025487A2 (en)
BR112013017878A2 (en)